EssilorLuxottica reported a 15 percent rise in first-half profit on Tuesday, beating analyst expectations as the eyewear giant capitalized on booming demand for AI-enabled smart glasses and childhood myopia management products. Revenue growth accelerated across both its prescription lens and branded eyewear divisions.
The myopia management segment—which encompasses spectacle lenses designed to slow the progression of nearsightedness in children—continued its rapid expansion, particularly across Asia-Pacific markets where governments have made childhood vision health a policy priority. This category now represents a meaningful growth engine beyond the company’s core prescription lens business.
CEO Francesco Milleri framed the results as validation of the company’s dual-pronged strategy: investing in cutting-edge technology while expanding access to essential vision care. “We are at the intersection of health, technology, and style,” Milleri said during the earnings presentation.
The company, which owns Ray-Ban, Oakley, and Sunglass Hut while manufacturing lenses for much of the optical industry, has emerged as an unexpected beneficiary of the wearable technology boom. Its partnership with Meta on the Ray-Ban Meta smart glasses line has generated particular momentum, with sales volumes exceeding internal forecasts.
